Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
The Role of HDACs as Leukemia Therapy Targets using HDI
Ahmad Ahmadzadeh, Elahe Khodadi, Mohammad Shahjahani, Jessika Bertacchini, Tina Vosoughi, Najmaldin Saki
Published: 2016-02-09
Thalidomide is more efficient than sodium butyrate in enhancing GATA-1 and EKLF gene expression in erythroid progenitors derived from HSCs with β-globin gene mutation
Mohammad Ali Jalali Far, Ali Dehghani Fard, Saiedeh Hajizamani, Majid Mossahebi-Mohammadi, Hamid Yaghooti, Najmaldin Saki
Published: 2016-04-08
The Emerging role of Immunomodulatory Agents in Fetal Hemoglobin Induction
Ali Dehghani-Fard, Saeid Kaviani, Najmaldin Saki, Esmaeil Mortaz
Published: 2015-10-13
Hypermethylation Status of Promoter is an Epigenetic Change in Lymphoied Malignancies
Majid Farshdousti Hagh, Najmaldin Saki, Gholamreza Khamisipour
T-cell Acute Lymphoblastic Leukemia with del (7) (q11.2q22) and Aberrant Expression of Myeloid Markers
Ahmad Ahmadzadeh, Sajedeh Saedi, Kaveh Jaseb, Ali Amin Asnafi, Arash Alghasi, Najmaldin Saki
Epigenetic Modulations on the Fetal Hemoglobin Induction
Saeid Kaviani, Mehrdad Noruzinia, Najmaldin Saki, Esmaeil Mortaz
The Role of Epigenetics in the Induction of Fetal Hemoglobin: A Combination Therapy Approach
Mohammad Ahmadvand, Mehrdad Noruzinia, Ali Dehghani Fard, Mostafa Montazer Zohour, Mohammad Amin Tabatabaiefar, Masoud Soleimani, Saeid Kaviani, Saeid Abroun, Sahar Beiranvand, Najmaldin Saki
Feasibility of cell therapy in Multiple Sclerosis: A systematic review of 83 studies
Abdolreza Ardeshiry Lajimi, Majid Farshdousti Hagh, Najmaldin Saki, Esmaeil Mortaz, Masoud Soleimani, Fakher Rahim
Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens
Ahmad Ahmadzadeh, Mir Saeed Yekaninejad, Mohamad H Jalili, Mohammad Bahadoram, Mehdi Efazat, Mohammad Seghatoleslami, Fatemeh Yazdi, Mozhdeh Mahdipour, Armita Valizadeh, Najmaldin Saki
The emerging role of mesenchymal stem cells in tissue engineering
Ali Dehghanifard, Mohammad Shahjahani, Masoud Soleimani, Najmaldin Saki
Molecular Mechanisms of Hemoglobin F Induction
Majid Farshdousti Hagh, Ali Dehghani Fard, Najmaldin Saki, Mohammad Shahjahani, Saied Kaviani
Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRAN
Sajedeh Saeidi, Kaveh Jaseb, Ali Amin Asnafi, Fakher Rahim, Fatemeh Pourmotahari, Samira Mardaniyan, Homayoon Yousefi, Arash Alghasi, Mohammad Shahjahani, Najmaldin Saki
Prenatal Diagnosis of Different Polymorphisms of β-globin Gene in Ahvaz
Ali Dehghanifard, Mohammad Shahjahani, Hamid Galehdari, Fakher Rahim, Fatemeh Hamid, Kaveh Jaseb, Ali Amin Asnafi, Mohammad Ali Jalalifar, Najmaldin Saki
Involvement of MicroRNA in T-Cell Differentiation and Malignancy
Najmaldin Saki, Saeid Abroun, Masoud Soleimani, Saeideh Hajizamani, Mohammad Shahjahani, Richard E Kast, Yousef Mortazavi
Adverse Effect of High Glucose Concentration on Stem Cell Therapy
Najmaldin Saki, Mohammad Ali Jalalifar, Masoud Soleimani, Saeideh Hajizamani, Fakher Rahim
Lymphoid Genes Expression in Mouse Embryonic Stem Cells with Differentiation on Feeder Free Condition
Majid Mossahebimohammadi, Saeid Kaviani, Mina Soufizomorrod, Masoud Soleimani, Saeid Abroun, Gholamreza Khamisipour, Najmaldin Saki
1 - 16 of 16 items


2025 CiteScore: 1.0

pISSN: 2008-3009
eISSN: 2008-2207

 

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

Chairman:
Ghasem Janbabaei

 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.0
2025CiteScore
 
 
30th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.